Vanguard Personalized Indexing Management, LLC
Position in PLRX — Pliant Therapeutics, Inc.
CIK 1767306
OAKLAND, CA
Position in PLRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$12,636
-$19,373 QoQ
Shares Held
10,029
-61.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 85.7413500847542.ToString("F0")%
Shared 0.ToString("F0")%
None 14.258649915245789.ToString("F0")%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vanguard Personalized Indexing Management, LLC holds $87,929,796 across 143 Biotechnology names. PLRX ranks #136 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
41,623 | $18,586,334 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,633 | $9,760,761 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12,215 | $4,041,577 | |
| 4 | INCY |
Incyte Corp
|
32,067 | $3,018,146 | |
| 5 | QNCX |
Quince Therapeutics, Inc.
|
132,661 | $2,679,752 | |
| 6 | ARGX |
Argenx SE
|
3,136 | $2,290,064 | |
| 7 | MRNA |
Moderna, Inc.
|
43,461 | $2,207,818 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
29,485 | $1,905,615 |
All Filings in PLRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,636 | 10,029 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $32,009 | 26,237 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $51,419 | 34,743 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $41,226 | 35,540 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $21,897 | 16,220 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||